Free Trial

Mn Services Vermogensbeheer B.V. Sells 3,000 Shares of DaVita Inc. $DVA

DaVita logo with Medical background

Key Points

  • Mn Services Vermogensbeheer B.V. has reduced its stake in DaVita Inc. by 15.5%, owning 16,380 shares worth $2,333,000 after selling 3,000 shares in Q2.
  • Several institutional investors, including UMB Bank n.a. and the National Pension Service, have increased their positions in DaVita, which is now 90.12% owned by institutional investors.
  • Analysts have mixed views on DaVita, with one upgrading the stock to a "buy" rating while others have lowered price targets, resulting in an average consensus target of $158.00.
  • Five stocks to consider instead of DaVita.

Mn Services Vermogensbeheer B.V. lowered its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 15.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,380 shares of the company's stock after selling 3,000 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in DaVita were worth $2,333,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its stake in shares of DaVita by 2.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock worth $531,000 after acquiring an additional 69 shares in the last quarter. UMB Bank n.a. grew its position in DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in DaVita by 8.9% in the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock valued at $148,000 after buying an additional 79 shares during the last quarter. Mather Group LLC. increased its stake in DaVita by 7.0% in the 1st quarter. Mather Group LLC. now owns 1,201 shares of the company's stock valued at $184,000 after buying an additional 79 shares during the last quarter. Finally, National Pension Service lifted its position in shares of DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company's stock worth $30,000 after buying an additional 84 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.50% of the company's stock.

DaVita Price Performance

DaVita stock traded up $1.14 during midday trading on Tuesday, hitting $132.29. 233,106 shares of the company's stock were exchanged, compared to its average volume of 858,359. DaVita Inc. has a 52-week low of $126.07 and a 52-week high of $179.60. The stock has a 50-day moving average price of $136.91 and a two-hundred day moving average price of $140.91. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. The company has a market cap of $9.46 billion, a P/E ratio of 13.01, a PEG ratio of 0.93 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same period in the prior year, the business earned $2.00 EPS. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Bank of America reduced their target price on DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a report on Wednesday, September 10th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Truist Financial set a $148.00 price target on DaVita in a report on Friday, August 8th. Finally, Barclays dropped their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, DaVita currently has a consensus rating of "Reduce" and an average price target of $158.00.

Check Out Our Latest Research Report on DaVita

DaVita Company Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.